Targeting triple-negative breast cancer cells with the histone deacetylase inhibitor panobinostatChandra R. Tate, Bridgette M. Collins‐Burow|Breast Cancer Research|2012Cited by 263
Regulation of triple-negative breast cancer cell metastasis by the tumor-suppressor liver kinase B1Lyndsay V. Rhodes, Bridgette M. Collins‐Burow|Oncogenesis|2015Cited by 35
Evaluation of deacetylase inhibition in metaplastic breast carcinoma using multiple derivations of preclinical models of a new patient-derived tumorTiffany Chang, Bridgette M. Collins‐Burow|PLoS ONE|2020Cited by 18